Healthcare: There's Smoke, Will There Be Fire?
Industry Focus
The Motley Fool
4.6 • 854 Ratings
🗓️ 14 December 2016
⏱️ 19 minutes
🧾️ Download transcript
Summary
Alexion's top-brass has hit the exits amid an investigation into sales practices, and Ophthotech's future is in jeopardy following a high-profile phase 3 failure.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day. |
| 0:07.0 | I'm your host Christine Hargis and it is December 14th. |
| 0:11.0 | As usual for a Wednesday, we'll be talking about the health care sector and I have got health care contributor Todd Campbell on the line |
| 0:16.9 | Todd is there anything new and exciting in your life since last Wednesday when we spoke? |
| 0:22.0 | No, not too much just battling a little bit of a cold I suppose and I suppose there is one good thing. My son who's in the Navy is off to Seattle for his next post and that's pretty exciting to see him moving on to that next area of his life. |
| 0:37.4 | Very cool. Does that mean that you get to take a trip out there? Oh yeah, we're already starting to plan it out. I'm looking forward to getting all sorts of |
| 0:46.1 | recommendations of great places to eat and hang out. |
| 0:49.4 | Hey if we have any listeners out in that area send them on into industry focus at fool.com, tell Todd where to go. |
| 0:55.0 | Fantastic. |
| 0:58.0 | So for today's episode, we will be discussing two news items from Monday of this week, one involving an eye disease drug |
| 1:04.4 | maker's clinical trial flop and the other one is about a management shakeup at a |
| 1:08.8 | rare disease drug company. But first I want to do a quick update from last week's episode and point out that Obama has officially signed the 21st century Curze Act into law as of yesterday. |
| 1:20.0 | As a reminder, this provides over $ billion in spending on medical innovation and it also |
| 1:25.3 | streamlines the drug and device approval process at the FDA. |
| 1:29.6 | If you missed last week's episode you can find it at pod dot fool.com you can also find all of the |
| 1:34.8 | Molly Fool's podcast on there and while you're online if you're interested in learning |
| 1:38.8 | about the foolish approach to options we've been talking about that a little bit here and there on the show and it always |
| 1:44.3 | gets a lot of people excited in writing in. So we have a landing page for it now and you can check |
| 1:48.8 | it out at full.com slash options focus and there's a bunch of good free material on there. |
| 1:55.0 | Our foolish approach to options has been extremely successful. |
| 1:58.0 | So check it out if you're interested. |
| 1:59.0 | Todd, do you want to tee off the first topic for today? |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.